The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) has named Jehan Mousa and Diederik De Graef as their 2021 Career Enhancement Fellows.
Jehan Mousa joined the FCDGC research team in September 2021. She is a rheumatology resident from Damascus University Hospitals, Syria. Her main interest is clinical research in congenital disorders of glycosylation (CDG) and education in rare disease. She is an Educational Research Fellow working with Eva Morava-Kozicz, MD, PhD, at Mayo Clinic. She is excited to explore all the clinical aspects of CDG from the point of diagnosis to the follow-up plan. As part of the Mayo Clinic CDG research team, she will support and educate CDG patients on genetic and metabolic aspects of their disease.
Diederik De Graef joined the FCDGC research team in September 2021. He is a medical student from the University of Leuven in Belgium. His main interest is in genetic and clinical research in CDG. He is a Research Trainee working with Eva Morava-Kozicz, MD, PhD, at Mayo Clinic until June 2022. He hopes to contribute to the Mayo Clinic CDG research team and help CDG patients while learning about the disease.
The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). FCDGC is funded under grant number U54NS115198 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS).